Low-density lipoproteins induce the renin-angiotensin system and their receptors in human endothelial cells

被引:53
作者
Catar, R. A.
Mueller, G.
Heidler, J.
Schmitz, G.
Bornstein, S. R.
Morawietz, H.
机构
[1] Department of Vascular Endothelium and Microcirculation, Medical Clinic and Policlinic III, University of Technology Dresden, Dresden
[2] Institute of Clinical Chemistry and Laboratory Medicine, University of Regensburg, Regensburg
[3] Department of Endocrinology, Diabetes and Metabolism, Medical Clinic and Policlinic III, University of Technology Dresden, Dresden
[4] University of Technology Dresden, Carl Gustav Carus Medical School, Department of Vascular Endothelium and Microcirculation, 01307 Dresden
关键词
endothelial cells; low-density lipoprotein; oxLDL receptor; renin-angiotensin system;
D O I
10.1055/s-2007-991158
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Increased levels of low-density lipoproteins are well-established risk factors of endothelial dysfunction and the metabolic syndrome. In this study, we evaluated the effect of native low-density lipoprotein (nLDL) and oxidized LDL (oxLDL) on the expression of genes of the renin-angiotensin system (angiotensin-converting enzyme, ACE; angiotensin 11 type I receptor, AT,) and their receptors (low-density lipoprotein receptor: LDLR; lectin-like oxLDL receptor: LOX-1; toll-like receptor 4: TLR4) in primary cultures of human umbilical vein endothelial cells. ACE and AT, expressions were significantly increased after stimulation with nLDL and oxLDL. OxLDL receptor LOX-1 showed a maximum induction after 7 hours. Increased LOX-1 protein expression in response to oxLDL could be blocked by a LOX-1 specific antibody. TLR4 expression was increased by nLDL and oxLDL as well. We conclude that LDL and oxLDL can activate the renin-angiotensin system and their receptors LDLR, LOX-1, and TLR4 in human endothelial cells. These data suggest a novel link between hypercholesterolemia and hypertension in patients with the metabolic syndrome.
引用
收藏
页码:801 / 805
页数:5
相关论文
共 35 条
[1]   The metabolic syndrome and cardiovascular disease [J].
Bonora, E .
ANNALS OF MEDICINE, 2006, 38 (01) :64-80
[2]   Toll-like receptors, endocrine stress response, and arteriosclerosis [J].
Bornstein, SR ;
Morawietz, H .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (09) :E135-E135
[3]   Toll-like receptor 2 and toll-like receptor 4 expression in human adrenals [J].
Bornstein, SR ;
Schumann, RR ;
Rettori, V ;
McCann, SM ;
Zacharowski, K .
HORMONE AND METABOLIC RESEARCH, 2004, 36 (07) :470-473
[4]   LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis [J].
Chen, MJ ;
Masaki, T ;
Sawamura, T .
PHARMACOLOGY & THERAPEUTICS, 2002, 95 (01) :89-100
[5]   Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study [J].
Deedwania, Prakash ;
Barter, Philip ;
Carmena, Rafael ;
Fruchart, Jean-Charles ;
Grundy, Scott M. ;
Haffner, Steven ;
Kastelein, John J. P. ;
LaRosa, John C. ;
Schachner, Holly ;
Shepherd, James ;
Waters, David D. .
LANCET, 2006, 368 (9539) :919-928
[6]   Scavenger receptors and oxidized low density lipoproteins [J].
Dhaliwal, BS ;
Steinbrecher, UP .
CLINICA CHIMICA ACTA, 1999, 286 (1-2) :191-205
[7]  
Dimmeler S, 1997, CIRCULATION, V95, P1760
[8]   Bacterial lipopolysaccharide activates NF-κB through Toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells -: Differential expression of TLR-4 and TLR-2 in endothelial cells [J].
Faure, E ;
Equils, O ;
Sieling, PA ;
Thomas, L ;
Zhang, FX ;
Kirschning, CJ ;
Polentarutti, N ;
Muzio, M ;
Arditi, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (15) :11058-11063
[9]   The hypertension-lipid connection: Insights into the relation between angiotensin II and cholesterol in atherogenesis [J].
Ferrario, CM ;
Smith, R ;
Levy, P ;
Strawn, W .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2002, 323 (01) :17-24
[10]   Hypertension mega-trials with cardiovascular end points: Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers [J].
Kjeldsen, SE ;
Julius, S .
AMERICAN HEART JOURNAL, 2004, 148 (05) :747-754